We have an established track record of excellence in R&D. Our commitment to innovation and continuous improvement has enabled us to remain at the forefront of pharmaceutical advancements in the CDMO sector. Our R&D teams are dedicated to developing differentiated dosages, enhancing manufacturing processes, and exploring novel therapeutic areas. Our R&D initiatives are aimed at innovation in relation to taste and odour masking, targeted drug release, solubility/dissolution enhancement, reduced excipient burden, permeation enhancement, and stability enhancement, among others. Our focus on R&D has resulted in the development of 220+ innovative formulations since the commencement of our operations.
Quality designed, Well equipped lab scale development facility to replicate & develop unique formulation with proper developmental designs.
Advanced analytical instruments with dedicated team expertise in various techniques to perform method development & validation.
Dedicated team to ensure time-bound delivery by tracking and communicating with internal as well as external stakeholders to ensure maximum productivity.
Regulatory assistance to ensure compliance with global pharmaceutical regulations, facilitating successful drug development and manufacturing for partners.
Separate dedicated teams for different segments having excellent skills in dossiers submission and licensing approval across the regions.
Akums' technology transfer expertise facilitates effective implementation of drug development and manufacturing innovations, maintaining high-quality standards and regulatory compliance.